AlternativeMed
Symptoms Conditions Remedies Herbs Ingredients Medications Genes
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Head And Neck Carcinoma

Open on HERB 2.0 ↗
1
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT01831089
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
Completed · Phase 1
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Head And Neck Carcinoma
🏥 Names
Disease Name
Head And Neck Carcinoma
Alias Names
Head And Neck Squamous Cell Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Neoplasms
DO Class
disease of cellular proliferation
🔗 External References
HERB DB
HBDIS022695 ↗
Disease Ontology
5520
DisGeNET
C3887461
🔍 Raw view — every non-empty column on this row (25 fields)
name
Head And Neck Carcinoma
alias name
Head And Neck Squamous Cell Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Neoplasms
do disease class
disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04
do disease class id
DOID:14566
herb disease id
HBDIS022695
disgenet id
C3887461
do id
5520

⚗️ Related Ingredients

1 · compounds in this herb
Taxol

📋 Clinical Trials

1 · subject of clinical study
NCT01831089 Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or
→ Breast Cancer|Ovarian Cancer|Gynecological Cancer|
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables